Status:
UNKNOWN
Cliavist in Infectious and Degenerative Diseases of the Spine
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Spine Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
USPIO contrast enhancement results from intracellular trapping of the iron particles in reactive cells, especially macrophages. 17FDG-PET studies have demonstrated that macrophages are present in spin...
Eligibility Criteria
Inclusion
- spine infection or spine degenerative disease
- patient agreement obtained
Exclusion
- pregnancy
- MRI contra-indications
- cliavist contra-indication
- dextran allergy
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00372281
Start Date
March 1 2007
End Date
December 1 2009
Last Update
February 25 2009
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Neuroradiologie - Hôpital Central
Nancy, France, 54035
2
Nouvel Hôpital Civil
Strasbourg, France, 67091
3
Service de Radiologie 2 - Hôpital de Hautepierre
Strasbourg, France, 67098
4
Service de Rhumatologie - Hôpital de Hautepierre
Strasbourg, France, 67098